Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Cancer Therapeutics Insights

Microtubule Dynamics Control Tail Retraction in Migrating Vascular Endothelial Cells

Anutosh Ganguly, Hailing Yang, Hong Zhang, Fernando Cabral and Kamala D. Patel
Anutosh Ganguly
1Department of Physiology and Pharmacology, Snyder Institute for Chronic Diseases, University of Calgary, Calgary, Alberta, Canada; 2Department of Integrative Biology and Pharmacology, University of Texas Medical School; and 3University of Texas, MD Anderson Cancer Center, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hailing Yang
1Department of Physiology and Pharmacology, Snyder Institute for Chronic Diseases, University of Calgary, Calgary, Alberta, Canada; 2Department of Integrative Biology and Pharmacology, University of Texas Medical School; and 3University of Texas, MD Anderson Cancer Center, Houston, Texas
1Department of Physiology and Pharmacology, Snyder Institute for Chronic Diseases, University of Calgary, Calgary, Alberta, Canada; 2Department of Integrative Biology and Pharmacology, University of Texas Medical School; and 3University of Texas, MD Anderson Cancer Center, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hong Zhang
1Department of Physiology and Pharmacology, Snyder Institute for Chronic Diseases, University of Calgary, Calgary, Alberta, Canada; 2Department of Integrative Biology and Pharmacology, University of Texas Medical School; and 3University of Texas, MD Anderson Cancer Center, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fernando Cabral
1Department of Physiology and Pharmacology, Snyder Institute for Chronic Diseases, University of Calgary, Calgary, Alberta, Canada; 2Department of Integrative Biology and Pharmacology, University of Texas Medical School; and 3University of Texas, MD Anderson Cancer Center, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kamala D. Patel
1Department of Physiology and Pharmacology, Snyder Institute for Chronic Diseases, University of Calgary, Calgary, Alberta, Canada; 2Department of Integrative Biology and Pharmacology, University of Texas Medical School; and 3University of Texas, MD Anderson Cancer Center, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1535-7163.MCT-13-0401 Published December 2013
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Additional Files
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    The effect of microtubule inhibitors on cell proliferation and cell migration. Paclitaxel (A), vinblastine (B), and colchicine (C) were tested for their ability to inhibit cell migration using a wound-healing scratch assay (open squares, solid lines), and for their ability to block cell division measured as an increase in the mitotic index (solid circles, dotted lines).

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Changes in select parameters of dynamic instability in cells treated with microtubule inhibitors. HUVEC were transfected with EGFP-MAP4 and microtubule behavior was measured in varying concentrations of paclitaxel (A), vinblastine (B), and colchicine (C). The plots show the effects of drugs on various parameters of dynamic instability (colored lines) superimposed on the drug effects on cell motility determined from a wound-healing scratch assay (solid circles, black line).

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Asymmetric distribution of dynamic microtubules. A, HUVEC cell migrating into a scratch wound. The cell was transfected with EGFP-MAP4 to visualize the microtubules. Left, the leading edge; and right, the trailing edge. Areas that were monitored by time lapse are outlined in red. Scale bar, 7 μm. B, time-lapse sequences of regions a and b from the leading edge. Photographs shown have been taken at intervals of 10 seconds apart. A few microtubules are traced in red to aid the viewer. C, time-lapse sequences of regions c and d from the trailing edge. Photographs shown have been taken at intervals of 10 seconds. In contrast to the static microtubules at the leading edge, many of the microtubules in the trailing edge were seen to grow (arrows) or shorten (arrowheads). D, quantification of the percentage of the time microtubules were growing, shortening, or pausing at the leading or trailing edges of the cell. The calculated dynamicity of the microtubules is also plotted on a separate scale. All the differences shown between the leading and trailing edges were found to be significant. *, P < 0.05; **, P < 0.01.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Membrane activity in HUVEC. A time-lapse series of images taken at intervals of 1 minute were analyzed by measuring the distance of the leading (solid line) and trailing (dotted line) edges from the nucleus. Untreated cells (A), cells treated with 1 nmol/L paclitaxel to suppress microtubule dynamics (B), cells treated with 2 nmol/L colchicine to suppress microtubule dynamics (C), and cells treated with 100 nmol/L vinblastine to eliminate the microtubules (D) are shown. Both edges exhibited relatively rapid fluctuations in the distance of the membrane from the nucleus. However, the trailing edge of control cells [dotted line in (A)] also exhibited a periodic rise and fall that we interpret as stretching and release of the trailing edge during cell migration. We define the time between successive peaks as the periodicity. Membrane activity, defined as the average rate of membrane displacement from the nucleus is plotted in E. *, P < 0.05; **, P < 0.01; ***, P < 0.001.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Migration paths of individual cells. Time-lapse movies of HUVEC moving into a scratch wound were analyzed by plotting the nuclear positions of individual cells at 15-minute intervals. The direction of the wound is toward the right. A, untreated cells. Circles represent the position of the nucleus at time zero and every 15 minutes thereafter. B, cells treated with 1 nmol/L paclitaxel to suppress microtubule dynamics. Shaded circles indicate the lack of any movement for one or more 15-minute intervals. Gray, no change in position for two to three 15-minute intervals; black, no change in position for four or more 15-minute intervals. C, cells treated with 2 nmol/L colchicine to suppress microtubule dynamics. Shaded circles have the same meaning as in the previous panel. D, cells treated with 100 nmol/L vinblastine to eliminate the microtubules. Circles were omitted because of extensive overlap.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    In vitro angiogenesis assay showing capillary-like tube formation on Matrigel. HUVECs were plated at a subconfluent density on Matrigel and their ability to form tubes was measured after 5 hours without (A) and with (B) 1 nmol/L paclitaxel. The cells were stained with calcein for 30 minutes and observed with the aid of a ×4 fluorescence objective. Quantification of tube formation by measuring tube length or area gave similar results that are plotted in C as a function of paclitaxel concentration. Closed circles and solid line, drug effects on cell migration using a wound-healing assay; open circles and dotted line, drug effects on tube formation.

Additional Files

  • Figures
  • Supplementary Data

    Files in this Data Supplement:

    • Supplementary Figure Legend - PDF file - 56K
    • Supplementary Figure 1 - PDF file - 94K, Supplementary figure 1. Structures of drugs used in these studies.
    • Supplementary Figure 2 - PDF file - 187K, Supplementary figure 2. Immunofluorescence microscopy of drug treated HUVEC.
    • Supplementary Tables 1 - 4 - PDF file - 78K, Table S1. Microtubule dynamics in HUVEC in the presence and absence of paclitaxel. Table S2. Microtubule dynamics in HUVEC in the presence and absence of vinblastine. Table S3. Microtubule dynamics in HUVEC in the presence and absence of colchicine. Table S4. Microtubule dynamics in the leading and trailing edges of HUVEC.
    • Supplementary Video 1 - MOV file - 3617K, Migration of HUVEC.
    • Supplementary Video 2 - MOV file - 3602K, Migration of HUVEC in the presence of 1 nM paclitaxel.
    • Supplementary Video 3 - MOV file - 3630K, Migration of HUVEC in the presence of 100 nM vinblastine.
PreviousNext
Back to top
Molecular Cancer Therapeutics: 12 (12)
December 2013
Volume 12, Issue 12
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Cancer Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Microtubule Dynamics Control Tail Retraction in Migrating Vascular Endothelial Cells
(Your Name) has forwarded a page to you from Molecular Cancer Therapeutics
(Your Name) thought you would be interested in this article in Molecular Cancer Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Microtubule Dynamics Control Tail Retraction in Migrating Vascular Endothelial Cells
Anutosh Ganguly, Hailing Yang, Hong Zhang, Fernando Cabral and Kamala D. Patel
Mol Cancer Ther December 1 2013 (12) (12) 2837-2846; DOI: 10.1158/1535-7163.MCT-13-0401

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Microtubule Dynamics Control Tail Retraction in Migrating Vascular Endothelial Cells
Anutosh Ganguly, Hailing Yang, Hong Zhang, Fernando Cabral and Kamala D. Patel
Mol Cancer Ther December 1 2013 (12) (12) 2837-2846; DOI: 10.1158/1535-7163.MCT-13-0401
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Authors' Contributions
    • Grant Support
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Tunicamycin Potentiates Cisplatin Anticancer Efficacy in Hepatocellular Carcinoma
  • Her-2 Modulation by Entinostat Reverses Letrozole Resistance
  • c-Met Inhibition in Metastatic Uveal Melanoma Model
Show more Cancer Therapeutics Insights
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement